Bright Minds Biosciences Retained Earnings (Accumulated Deficit) 2022-2024 | DRUG

Bright Minds Biosciences retained earnings (accumulated deficit) from 2022 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Bright Minds Biosciences Retained Earnings (Accumulated Deficit) 2022-2024 | DRUG

Bright Minds Biosciences retained earnings (accumulated deficit) from 2022 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.